ACSS2 and obesity due to melanocortin 4 receptor deficiency: In addition to D-mannose clinical application in treating cancer, urinary infections, type 1 diabetes and diabetic wounds, we also support the possibility of putting forth D-mannose as a potential therapeutic strategy of obesity and its related disorders via ACSS2.